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B cell development depends on the coordinated
expression and cooperation of several transcription
factors. Here we show that the transcription factor
ETS-related gene (ERG) is crucial for normal B cell
development and that its deletion results in a sub-
stantial loss of bone marrow B cell progenitors and
peripheral B cells, as well as a skewing of splenic B
cell populations. We find that ERG-deficient B line-
age cells exhibit an early developmental block at
the pre-B cell stage and proliferate less. The cells
fail to express the immunoglobulin heavy chain due
to inefficient V-to-DJ recombination, and cells that
undergo recombination display a strong bias against
incorporation of distal V gene segments. Further-
more, antisense transcription at PAX5-activated in-
tergenic repeat (PAIR) elements, located in the distal
region of the Igh locus, depends on ERG. These find-
ings show that ERG serves as a critical regulator of B
cell development by ensuring efficient and balanced
V-to-DJ recombination.
INTRODUCTION
B cells are central players in the adaptive immune system, in
which they fight various foreign antigens, which is made
possible by their ability to synthesize a vastly diverse B cell an-
tigen receptor (BCR) repertoire. The BCRs are generated during
B cell development, which in the adult takes place in the bone
marrow (BM), before the resulting immature B cells migrate to
the spleen, where they undergo further maturation to naive B
cells. In the BM, hematopoietic progenitors develop into B cells
by passing through several progenitor stages in a highly regu-
lated process. Key to this process is transcriptional control,
and several transcription factors have been identified as essen-
tial regulators of B cell development (Sigvardsson, 2018).2756 Cell Reports 29, 2756–2769, November 26, 2019 ª 2019 The A
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together to facilitate restriction and commitment to the B cell
lineage during early B cell development (Lin et al., 2010; Nutt
et al., 1999). Apart from transcriptional regulators, ordered
expression of key cell surface receptors such as the interleukin
7 receptor (IL7R), pre-BCR, and BCR, is also required to faith-
fully execute the B cell developmental program (Kitamura
et al., 1991; Pelanda et al., 2002; Peschon et al., 1994; Zou
et al., 2003).
The main mechanism underlying the ability of B cells to obtain
a large BCR repertoire is the process of V(D)J recombination.
During this process, immunoglobulin gene segments are recom-
bined sequentially; the immunoglobulin heavy-chain (Igh) locus
is recombined before the immunoglobulin light-chain (Igl) loci.
Furthermore, recombination of the Igh locus is a two-step pro-
cess in which D-to-J precedes V-to-DJ recombination. Once
in-frame recombination of the Igh locus has been obtained, syn-
thesis of the immunoglobulin m heavy chain (mHC) commences.
The mHC assembles with the surrogate light chain (SLC) to
form a pre-BCR and, subsequently, with the immunoglobulin
light chain to form a BCR (Perlot and Alt, 2008).
The murine Igh locus comprises a 3-Mb large region located
on chromosome 12 and encompasses 8 constant (C) regions,
4 J, 10 functional D, and just over 100 functional V gene seg-
ments. The latter are divided into 16 V gene families of varying
size that are dispersed over a2.5-Mb region, with the individual
families and members located different distances from the D
gene segments (Johnston et al., 2006). Recombination of the
Igh locus is both complex and highly regulated, and many
changes occur at the locus as a prelude to recombination. These
changes include nuclear relocalization, changes in DNA accessi-
bility, initiation of non-coding RNA transcription, and changes in
the 3D conformation of the locus (Kumari and Sen, 2015). The
latter is particularly important to obtain fairly even usage of V
gene segments, despite their different localizations relative to
the D genes. The resulting conformation of the Igh locus is char-
acterized by local loop domains and large-scale locus contrac-
tion that are facilitated by the binding of several factors (Degner
et al., 2011; Fuxa et al., 2004; Guo et al., 2011; Jhunjhunwalauthor(s).
creativecommons.org/licenses/by-nc-nd/4.0/).
et al., 2008; Kosak et al., 2002; Liu et al., 2007;Medvedovic et al.,
2013).
ETS-related gene (ERG), a member of the ETS domain family of
transcription factors, has been shown to be essential for definitive
hematopoiesis and to promote leukemic development (Baldus
et al., 2006; Loughran et al., 2008; Martens, 2011; Rainis et al.,
2005). Moreover, our group has identified ERG as a critical regu-
lator of hematopoietic stem cell maintenance (Knudsen et al.,
2015). Previous work has also hinted at a role for ERG in B cell
development. Specifically, overexpression of Erg was shown to
confer a survival advantage to progenitor B cells, and mice
harboring a heterozygous mutation in the ERG transactivation
domain exhibited a trend toward fewer peripheral B cells (Lough-
ranet al., 2008;Tsuzuki et al., 2011). ERGhasalsobeen linked toB
cell acute lymphoblastic leukemia (B-ALL), in which heterozygous
deletion of ERG, in combination with an IGH-DUX4 fusion, was
recently shown to define a novel B-ALL subtype (Lilljebjo¨rn et al.,
2016;Zhanget al., 2016).Collectively, theseobservations suggest
that ERG may play a role during normal B cell development.
In the present work, we set out to test the potential role of ERG
during B cell development. By using a lymphoid-restricted Erg
knockout mouse line, we showed that the ablation of Erg re-
sulted in a substantial reduction in peripheral B cell numbers
and a skewing in the ratio of splenic B cell subsets. We mapped
the loss of peripheral B cells to an early block in BM B cell devel-
opment and found that ERG-deficient progenitor B cells dis-
played decreased levels of the IL7R and the pre-BCR, thus re-
sulting in reduced proliferation. Mechanistically, we showed
that ERG-deficient progenitor B cells were unable to undergo
efficient Igh V-to-DJ recombination, as evidenced by fewer rear-
rangements and a strong bias against the use of distal V gene
segments. Altogether, these results identify ERG as a factor of
critical importance during early B cell development, with a spe-
cific role during Igh locus recombination.
RESULTS
ERG Is Required for Normal B Cell Development
To assess the role of ERG in lymphoid development, we intro-
duced the hCD2-iCre allele into our previously generated condi-
tional Erg mouse line, which facilitates deletion of the DNA
binding domain of ERG (de Boer et al., 2003; Knudsen et al.,
2015). Because the hCD2 promoter is activated at the common
lymphoid progenitor (CLP) stage, the resulting Ergfl/fl;CD2iCre
(from here on, ErgD/D) mice lack ERG activity in all lymphoid cells
(Figure 1A) (Schindler et al., 2009). Normally, Erg is expressed at
substantial levels in CLPs, and the expression is sustained dur-
ing the early stages of B and T cell development, as assessed
via publicly available gene expression repositories (Figures
S1A and S1B) (Bagger et al., 2016).
We first examined the cell lineage distribution in peripheral
blood from control and ErgD/D mice by flow cytometry. Loss of
ERG resulted in a marked reduction of peripheral blood B cells,
while the frequencies of T, myeloid, and natural killer (NK) cells
increased concomitantly (Figures 1B and 1C). This phenotype
was accompanied by a 50% drop in spleen and inguinal lymph
node masses, presumably due to the strong reduction of B cells
in these organs. (Figures 1D and 1E).Given the substantial decrease in peripheral B cell numbers,
we analyzed the splenic B cell compartment and noted a pro-
nounced skewing of B cell subsets in ErgD/D mice (Figures 1F
and 1G). Specifically, follicular (FO) B cells were dramatically
decreased, both in frequency and in number, while the opposite
was true for marginal zone (MZ) B cells. The frequency of B1
B cells was unaffected in ErgD/D mice, but we observed a mild
skewing in the B1 B cell subsets, resulting in an increased
B1a-to-B1b ratio (Figure S1C). Furthermore, the transitional
B cells were almost absent. Thus, the loss of ERG affected the
earliest splenic B cell populations, likely reflecting that fewer
immature B cells were seeding this organ.
The strong reduction in peripheral B cell frequencies following
lymphoid-specific loss of ERG could in principle mask a potential
T cell phenotype in ErgD/D mice (Figures 1B, 1C, and S1D). We
therefore assessed the thymic T cell compartment and found
no effects on relative frequencies ofmature T cells, although their
overall numbers were somewhat decreased (Figure S1E).
Furthermore, onlyminor changeswere detected in T cell progen-
itor numbers and frequencies (Figures S1E and S1F). Given that
the effect on B cells was more pronounced, we focused our ef-
forts on this compartment.
In summary, loss of ERG in the lymphoid compartment mark-
edly affects B cell numbers in peripheral blood and lymphoid or-
gans, which may be caused by lower efflux of immature B cells
from the BM.
ERG-Deficient Progenitors Encounter an Early B Cell
Developmental Block
The data presented so far suggest that ERG may play a role in
early B cell development, which is a continuous process taking
place in the BM (Figure 2A). To address the earliest stages of B
cell development, we first verified that deletion of Erg, in our
model, was initiated at the CLP stage and was efficient in all
tested downstream populations (Figure S2A). Lymphoid-specific
loss of ERG was only associated with a mild reduction in overall
BM cellularity, but this translated into a 6-fold reduction in the
number of B220+CD19+ cells, thus demonstrating a strong
impact on the B cell lineage (Figures 2B, 2C, and S2B).
We next combined panels of B lineage markers to pinpoint the
main stages of B cell development affected in ErgD/D animals.
Normally, upregulation of CD25 occurs at the pre-BI to pre-BII
transition, at which stage c-Kit has been downregulated and
pre-BCR signaling commences (Rolink et al., 1994). In ErgD/D
mice, we detected a tendency toward a reduction in the number
of c-Kit+ B cell progenitors and observed a clear population of
CD25+ cells, of which a small percentage expressed both c-Kit
and CD25, markers that are normally mutually exclusive (Figures
2D, 2F, and S2C). Furthermore, within the normal B cell
progenitor compartment, most cells that are CD43+ do not yet
express CD25 (herein P1; CD43+CD25), and vice versa (P3;
CD43CD25+) (Figures 2D–2F). In sharp contrast to control cells,
ErgD/D progenitors failed to downregulate CD43 and became ar-
rested at an unconventional CD43+CD25+ (P2) stage. The accu-
mulation of cells in P1 and P2 and the decrease in P3 cells
strongly suggest that pre-BCR signaling was derailed following
loss of ERG, and as a consequence, we decided to use the
CD43/CD25 marker combination for subsequent analyses.Cell Reports 29, 2756–2769, November 26, 2019 2757
Figure 1. ERG Is Required for Normal B Cell Development
(A) Deletion of the DNA-binding domain of Erg takes place at the CLP stage, leading to a pan-lymphoid loss of ERG.
(B) Flow cytometry analysis of peripheral blood from Ergfl/fl and Ergfl/fl;CD2iCre (ErgD/D) mice.
(C) Quantification of the flow analysis in (B), showing lineage frequencies in peripheral blood.
(D) Weights and B cell frequencies (B220+ cells, as determined by flow cytometry) of inguinal lymph nodes from Ergfl/fl and ErgD/D mice.
(E) Weights and B cell frequencies (B220+ cells, as determined by flow cytometry) of spleens from Ergfl/fl and ErgD/D mice.
(F) Flow cytometry analysis assessing the splenic B cell subsets of Ergfl/fl and ErgD/D mice. Cell populations were defined as shown by the gating strategy.
(G) Quantification of the flow cytometry analysis in (F). Left, the frequencies of the various B cell populations of the spleen. Right, total number of cells within each
population.
For the flow cytometry analyses, representative flow cytometry plots for the two genotypes are shown. For quantification, the data are shown as mean + SD.
Statistical analyses were performed using unpaired, two-tailed Student’s t test. *p% 0.05, **p% 0.01, ***p% 0.001, ****p% 0.0001. HSC, hematopoietic stem
cell; MPP, multipotent progenitor; CMP, common myeloid progenitor; CLP, common lymphoid progenitor; T, transitional; FO, follicular; MZ, marginal zone.
See also Figure S1.
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Heterozygous loss of ERG is associated with the development
of B-ALL, and we therefore tested whether ErgD/+ animals
display B cell abnormalities that could set the stage for cancer
development. However, we only detected minor changes in the
B cell lineage of these mice (Figures S2D and S2E). Moreover,
to assess whether the B cell phenotype reported earlier for
young ErgD/D mice progressed during aging, we phenotyped
aged (1.5 years) ErgD/D mice but found no evidence of further
phenotypic progression (Figures S2F–S2H). These data demon-
strate that the sole loss of ERG is not sufficient to drive develop-
ment of B cell malignancies.
Collectively, these findings suggest that the main function of
ERGduring B cell development is to efficiently push cells through
stages in which the Igh locus undergoes recombination and pre-
BCR expression is initiated.
ERG Is Required for the Expression of IL7R and mHC to
Drive B Cell Progenitor Proliferation
To directly examine whether loss of ERG was associated with
failure to initiate pre-BCR expression, we next quantified the
intracellular levels of the immunoglobulin mHC (Figures 3A and
3B). Strikingly, whereas mHCexpression in control micewas initi-
ated in P1 and reachedmaximum levels in P2, these two progen-
itor populations were nearly devoid of mHC in ErgD/D mice. Most
ErgD/D cells that did reach P3 displayed relatively normal mHC
levels, suggesting that the few cells that succeed in downregu-
lating CD43 are progenitors that express a pre-BCR. We also
measured the expression of IL7R, another essential receptor
for B cell development (Peschon et al., 1994), and found it to
be expressed throughout the P1–P3 progenitor populations,
albeit at lower levels in ErgD/D cells (Figures 3C and 3D). Because
both IL7R and pre-BCR have been associated with B cell pro-
genitor proliferation (Corcoran et al., 1996; Hess et al., 2001),
we next quantified the distribution of cells across the cell cycle
in the P1–P3 populations. Consistent with a proliferative pheno-
type, we found that loss of ERG led to a marked decrease of
cells in the S and G2/M phases of the cell cycle, accompanied
by a compensatory increase of cells in G0/G1 (Figures 3E and
3F). These data are supported by in vivo bromodeoxyuridine
(BrdU)-incorporation experiments, which demonstrated not
only a marked decrease in the frequencies of replicating progen-
itors in ErgD/D mice but also a reduction in the amount of label
incorporated in individual cells (Figures 3G and 3H). The latter
could reflect a lower DNA synthesis rate that would be expectedFigure 2. ERG-Deficient Progenitors Encounter an Early B Cell Develo
(A) Schematic figure of B cell development in the BM from the pro-B cell stage t
(B) Flow cytometry analysis of BM cells from Ergfl/fl and ErgD/D mice.
(C) Quantification of the analysis in (B). Top, frequency of the BM cells that are do
B220+CD19+ cells in the BM (23 femur, tibia, ilium) of Ergfl/fl and ErgD/D mice.
(D) Flow cytometry analysis of the B220+CD19+ compartment in Ergfl/fl and ErgD
(E) Schematic flow cytometry plot depicting the BM B cell progenitor population
(F) Quantification of the flow cytometry analysis seen in (D), according to the gat
within the indicated cell populations in the BM (23 femur, tibia, ilium) of Ergfl/fl a
B220+CD19+CD93+ progenitor and immature B cell gate. All populations are B2
populations.
For the flow cytometry analyses, representative plots are shown. For quantificatio
unpaired, two-tailed Student’s t test. *p% 0.05, **p% 0.01, ***p% 0.001, ****p
See also Figure S2.
2760 Cell Reports 29, 2756–2769, November 26, 2019to lead to an accumulation of cells in S phase. However, as we
observe accumulation of cells in G0/G1, we favor an interpreta-
tion in which loss of ERG leads to accumulation of cells at the
G1-S boundary and delayed entry into S phase.
In summary, loss of ERG is associated with major cell cycle
deficits during B cell development, likely caused by moderately
reduced levels of IL7R and failure to express a pre-BCR.
ERG Is Part of a B Cell Transcriptional Network that
Drives B Cell Development
To gain insights into the molecular mechanisms underlying
the block in B cell development in ERG-deficient mice, we next
subjected the P1–P3 populations to RNA sequencing (RNA-
seq) (Table S1). On the global level, we detected a substantial
number of deregulated genes in the ERG-deficient P1 and P2
progenitor populations (P1: 115 up, 118 down; P2: 91 up, 131
down; adjusted p value % 0.05; log2 fold change R 1 or %
1). In contrast, fewer genes were differentially expressed at
the P3 cell stage (P3: 37 up, 9 down; adjusted p value % 0.05;
log2 fold change R 1 or % 1), supporting the notion that the
main functional deficits following loss of ERG occur before
pre-BCR expression (Figure 4A). Consistent with the observed
cell cycle deficit, gene set enrichment analysis (GSEA) demon-
strated an overall depletion of gene signatures associated with
active cell proliferation (exemplified by E2F targets, G2M check-
point, and chromosome segregation) in all three ERG-deficient
progenitor subsets (Figure 4B; Table S2). We also noted a deple-
tion of a MYC target gene signature, as well as depletion of
several translation- and ribosome-related signatures in ErgD/D
P1 progenitors (Figure 4B; Table S2). This appears to be driven
by reduced Myc expression and is consistent with the well-
known impact of MYC on protein synthesis (Figure 4A) (van Rig-
gelen et al., 2010).
To understand the impact of ERG on chromatin accessibility
and how ERG integrates with established B cell transcription fac-
tors, we performed Assay for Transposase-Accessible Chro-
matin using sequencing (ATAC-seq) on control and ErgD/D pro-
genitor B cells. Consistent with the GSEA, we found that genes
associated with sites exhibiting decreased accessibility
following loss of ERG were downregulated and enriched for
Gene Ontology (GO) categories associated with proliferation
(Figures S3A–S3C). We next used the Integrated analysis
of Motif Activity and Gene Expression changes of transcription
factors (IMAGE) tool (Madsen et al., 2018) to determine changespmental Block
o mature B cells. Surface marker expression is annotated.
uble-positive for B220 and CD19. Bottom, total quantification of the number of
/D mice.
s called P1–P3.
ing strategy shown in the plots. Left, quantification of the total number of cells
nd ErgD/D mice. Right, frequency of the indicated cell populations within the
20+CD19+. Dashed lines separate progenitor B cells from more downstream
n, the data are shown as mean + SD. Statistical analyses were performed using
% 0.0001.
(legend on next page)
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in transcription factor motif activities following loss of ERG. IM-
AGE models the contribution of transcription factor motifs to
the regulatory activity of ATAC regions based on the ATAC-seq
signal and the presence of transcription factor motifs in ATAC re-
gions (n = 52,311). For the contribution of motifs to gene expres-
sion, motifs within the ATAC regions are weighted based on dis-
tance to the respective transcription start sites. Thus, changes in
motif activity between conditions, e.g., control and ErgD/D pro-
genitor B cells, indicate that a particular transcription factor con-
tributes differentially to the overall regulatory activity of ATAC re-
gions in the context of all analyzed motifs (Rauch et al., 2019).
Gratifyingly, we found that the ERG motif, together with the mo-
tifs of the two key B cell transcription factors, EBF1 and PAX5,
exhibited a marked reduction in regulatory activity following
loss of ERG (Figure S3D). Using the IMAGE tool-based predic-
tion of transcription factor target genes, we could show that tran-
scription factors with decreased motif activity in ErgD/D progen-
itor B cells were highly interconnected, e.g., regulated the
expression of each other, compared with those with increased
motif activity or randomized transcriptional networks (Figures
S3E and S3F). These findings suggest that ERG, together with
PAX5 and EBF1, is a key component of a large transcription fac-
tor network responsible for driving B cell development.
Having established the more global impact of ERG on B cell
transcriptional control, we turned our attention to the expression
of individual genes important for B cell development (Figure 4C).
Among B lineage factors, we detected a minor reduction in Ebf-1
expression (log2 fold change = 0.78; adjusted p value = 0.048).
However, because heterozygous loss of EBF-1 has a relatively
mild impact on B cell development, the observed reduction in
Ebf-1 expression is unlikely to explain the observedErgD/Dpheno-
type (Lukin et al., 2010). Loss of ERG is associatedwith a dramatic
reduction in mHC, and we therefore assessed the expression of
other pre-BCR components at the P1–P3 progenitor stages. At
the P1 stage, there were no significant differences in the expres-
sion of any of these receptor components. At the following cell
stages, the expression levels of the SLC genes (i.e., Igll1 and
Vpreb1) were downregulated in control cells, which is expected
subsequent to signaling from the pre-BCR (Parker et al., 2005).
An equivalent decrease in SLC gene expression was not
observed in the ErgD/D cells, likely due to a lack of pre-BCR
signaling. Strikingly, Erg displayed a similar expression profile,
perhaps suggesting that it is also downregulated in response toFigure 3. ERG Is Required for the Expression of IL7R and mHC to Drive
(A) Histograms showing the levels of intracellular immunoglobulin m heavy chain
tometry. Cells from four mice of each genotype were examined. The gray line illu
(B) Quantification of the flow cytometry analysis in (A). The percentages of mHC-
(C) Histograms showing the surface expression of IL7Ra on P1–P3 cells as assesse
cells.
(D) Quantification of the flow cytometry analysis in (C). MFI, median fluorescence
(E) Cell cycle analysis of P1–P3 cells from Ergfl/fl and ErgD/D mice as determined
(F) Quantification of the flow cytometry analysis in (E). The frequencies of cells foun
histogram plots.
(G) Mice were injected with BrdU, and the bones were harvested 3 h later. The h
ErgD/D mice as measured by flow cytometry.
(H) Quantification of the flow cytometry analysis in (G). The percentages of BrdU-
For the flow cytometry analyses, representative plots are shown. For quantificatio
unpaired, two-tailed Student’s t test. *p% 0.05, **p% 0.01, ***p% 0.001, ****p
2762 Cell Reports 29, 2756–2769, November 26, 2019pre-BCR signaling (Figure 4C). Finally, we noted a marked reduc-
tion in the expression of a substantial number of Igh locus V gene
segments in ErgD/D cells, especially in the P2 population, which
could explain the near absence of mHCexpression (Figure 4A, yel-
low dots). In contrast to the changes observed for the expression
of gene segments of the Igh locus, we did not observe significant
transcriptional changes at the immunoglobulin light-chain loci, as
assessed in the most mature P3 population (Table S1).
The reduction in Igh V gene segment expression does not
appear to be associated with changes in the expression of vital
genes encoding members of the recombination machinery or
regulators of the 3D structure of the locus (Figure 4C). In ErgD/D
P1 progenitors, we did observe a reduction in the expression
of Dntt, which encodes TdT, the protein that is responsible for
n-nucleotide incorporation during V(D)J recombination. How-
ever, this cannot account for the ErgD/D phenotype, because
Dntt-deficient mice do not display a B cell developmental pheno-
type (Schelonka et al., 2011).
Collectively, our chromatin and transcriptional analyses
demonstrate an integral role of ERG in a transcriptional network
driving B cell development. Moreover, they identify transcrip-
tional deregulation of Igh V gene segment expression as a poten-
tial cause of the B cell developmental phenotype in ErgD/Dmice.
Loss of ERG Abrogates Efficient V-to-DJ Recombination
Given that our functional and molecular analyses demonstrate
that the main consequence of ERG deficiency is centered on
the Igh locus, we were intrigued by the transcriptional downregu-
lation of several Igh V gene segments. We therefore analyzed the
RNA-seq data of all V gene segments, from proximal to distal, and
found a marked overall reduction in their expression in ErgD/D P1
and P2 progenitors (Figures 5A–5C). This reduction was less pro-
nounced in ErgD/D P3 progenitors, in which Igh recombination has
already occurred. Instead, we detected a clear preference for the
expression of proximal V gene segments in ErgD/D P3 progenitors
compared with their wild-type counterparts.
To determine whether the reduction in V gene segment expres-
sion was due to reduced V-to-DJ recombination, we next used
the high-throughput sequencing-based immunoSEQ platform to
assess the VDJ junctions of the Igh loci. This analysis revealed
a strong reduction in the total numbers of rearrangements in
ErgD/D P1 and P2 progenitors, whereas P3 and the mature FO
and MZ B cell populations were unperturbed (Figure 6A).B Cell Progenitor Proliferation
(IC mHC) in P1–P3 cells from Ergfl/fl and ErgD/D mice as assessed by flow cy-
strates the level of IC mHC in B220-CD19 cells.
positive cells were determined using the gating shown in the histogram plots.
d by flow cytometry. The gray line illustrates the level of IL7Ra onB220-CD19
intensity.
by DAPI staining using flow cytometry.
d in the different cell cycle stageswere determined using the gates shown in the
istograms depict the levels of incorporated BrdU in P1–P3 cells of Ergfl/fl and
positive cells were determined using the gating shown in the histogram plots.
n, the data are shown as mean + SD. Statistical analyses were performed using
% 0.0001.
Figure 4. Gene Expression Analysis of ERG-Deficient B Cell Progenitors
(A) RNA sequencing (RNA-seq) was performed on RNA in four biological replicates isolated from P1–P3 cells from Ergfl/fl and ErgD/D mice (see also Table S1).
Volcano plots depict differentially expressed genes between Ergfl/fl and ErgD/D cells in the P1 (left), P2 (middle), and P3 (right) populations. Selected genes are
highlighted by gene names and color coded in blue (down inErgD/D) or green (up in ErgD/D). IghV gene segments that are significantly deregulated are illustrated by
yellow dots (P1, 0 gene segments; P2, 20 gene segments; P3, 9 gene segments). Genes with a fold change of <8 or >8 are located at 8 or 8 on the x axis,
respectively.
(legend continued on next page)
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Moreover, the frequency of non-productive rearrangements was
increased in the P1 and P2populations (Figure 6B).We also found
that loss of ERG was associated with a reduction in complemen-
tary-determining region 3 (CDR3) length, which was most pro-
nounced at the early progenitor stages (Figure 6C). Finally,
when we quantified the frequencies of productive rearrange-
ments for distinct V gene segment families, there was a clear pref-
erence for the use of proximal families in ERG-deficient cells (Fig-
ures 6D, 6E, and S4A). Collectively, these data demonstrate that
ERG is required for efficient and balancedV-to-DJ recombination.
V-to-DJ recombination is governed by several distinct mecha-
nisms. Because the reduction in the use of distal V gene segments
in ERG-deficient progenitors could be due to decreased chro-
matin accessibility at these regions, we assessed the ATAC-seq
data, but we found no differences in the overall accessibility of
the locus (Figure 6F). Another feature that has been tightly linked
to V-to-DJ recombination is antisense transcription that is initiated
at regulatory PAX5-activated intergenic repeat (PAIR) elements in
the distal end of the Igh locus in progenitor B cells and that ceases
immediately after recombination (Ebert et al., 2011; Liu et al.,
2007; Verma-Gaur et al., 2012). PAIR elements have been shown
to be involved in contacts between the 50 and the 30 ends of the
locus, and in particular, PAIR4, PAIR6, and PAIR11 display high
levels of transcription. In accordance with these previous studies,
we observed high levels of antisense transcription at these PAIR
elements in control P1 progenitors, but not in the subsequent
P2 and P3 cell subsets (Figures 6G and S4B). In contrast, loss
of ERG nearly ablated expression of PAIR-associated antisense
RNA, suggesting a role for ERG in this process. In an attempt to
connect ERG binding in B cell progenitors to events at the Igh lo-
cus, we performed numerous chromatin immunoprecipitation
(ChIP) experiments but were unable to obtain high-quality data.
Instead, we took advantage of an existing dataset derived from
the immature murine hematopoietic HPC-7 cell line (Wilson
et al., 2010). Consistent with a role for ERG in mediating recombi-
nation involving distal V gene segments, ERG exhibits extensive
binding at these regions (Figure S4C).
In summary, we find that loss of ERG impairs V-to-DJ recom-
bination, in particular to distal V gene regions, and ablates PAIR-
associated antisense transcription.
DISCUSSION
Transcriptional control is key toBcell development, and in thepre-
sent work, we identify ERG as an important player in this process.
Using a lymphoid-specific Erg knockout mouse model, we
showed that loss of ERG resulted in an early block in B cell devel-
opment accompanied by loss of peripheral B cells, with the
intriguingexceptionofMZBcells. The inability ofErgD/DBcell pro-
genitors to efficiently synthesize mHC, and thus a pre-BCR, was
shown to be caused by derailed V-to-DJ recombination, charac-
terized by reduced recombination frequency and a proximal V(B) Gene set enrichment analysis (GSEA) (see also Table S2) of the RNA-seq dat
(C) Gene expression changes of selected genes as examined by RNA-seq. P1
respectively. Top, log2 fold change in gene expression, ErgD/D versus Ergfl/fl. Bott
(counts per million). *p% 0.05, **p% 0.01, ***p% 0.001, ****p% 0.0001.
See also Figure S3.
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opmental block at an unconventional CD43+CD25+ P2 cell stage
immediately before pre-BCR assembly. Normally CD25 is ex-
pressed concomitantly with the pre-BCR; however, this relation
is clearly short-circuited in the absence of ERG, indicating that
CD25 expression is driven by signals unrelated to V-to-DJ recom-
bination and mHC expression (Rolink et al., 1994). Consistent with
their inability to elicit proper pre-BCR signaling, ErgD/D B cell pro-
genitors display reduced proliferation rates, which is most likely
exacerbated by their inability to express normal levels of known
proliferative drivers such as IL7R and MYC (Corcoran et al.,
1996;Hess et al., 2001; Vallespino´s et al., 2011). Finally, transcrip-
tomic and chromatin accessibility analyses place ERG as a key
constituent of a transcription factor network important for B cell
development.
Apart from a marked general depletion of peripheral B cells,
our data demonstrate that ERG affects the relative distribution
of mature splenic B cell subsets, and specifically, we find that
the numbers of MZ B cells were augmented in ErgD/D mice.
VDJ sequencing showed that among the tested cell populations,
MZB cells had the shortest averageCDR3 length in control mice.
Furthermore, this was the only population in which we did not
observe any difference in the average CDR3 length between
ErgD/D and control cells. This suggests that the shorter CDR3s
in ErgD/D B lineage cells could influence the mature B cell pool.
In support of this, previous work has demonstrated that MZ B
cells have shorter CDR3s compared with FO B cells and that a
larger proportion of the MZ B cells harbors Igh rearrangements
lacking n-nucleotides (Carey et al., 2008; Prohaska et al.,
2018). Furthermore, loss of Dntt is associated with increased
MZ B cell potential (Carey et al., 2008). Thus, we propose that
the increase in MZ B cells in ErgD/D mice is due to a preference
of ERG-deficient progenitors to develop into the MZ lineage.
This priming takes place in the ErgD/D BM and is likely caused
by an overall truncation of the CDR3 or by reduced n-nucleotide
incorporation as a result of decreased Dntt expression. A direct
role of ERG in peripheral B cells is less probable given its low
expression in these cells (Figure S1A).
Wedemonstrated that the failure of theErgD/DprogenitorB cells
to efficiently express the mHCwas associated with a strong V(D)J
recombination deficiency. Not only were overall recombination
frequencies reduced, but productively rearranged alleles were
markedly depleted for distal V gene segments. Part of the recom-
bination deficiency could be caused by reduced D-to-J recombi-
nation rates, which would result in fewer V-to-DJ recombination
events. In this scenario, recombination to both proximal
(IghV2+IghV5) and distal (IghV1+IghV8) V gene segments would
be expected to be decreased. However, we only observe a signif-
icant decrease in the number of rearrangements involving distal,
but not proximal, V gene segments when assessed in the imma-
ture P1 progenitor population. Although we cannot rule out an ef-
fect onDJ recombination, this finding indicates that themainV(D)Ja of the three progenitor populations, ErgD/D versus Ergfl/fl.
, P2, and P3 populations are represented with green, purple, and pink bars,
om, average gene expression values in Ergfl/fl cells, depicted as average CPM
(legend on next page)
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recombination deficiency observed in ErgD/D progenitor B cells is
caused by the inefficient use of distal V gene segments.
Efficient V-to-DJ recombination involving distal V gene seg-
ments is associated with major structural changes at the Igh lo-
cus to bring the 30 and the 50 ends into proximity in a process
termed locus contraction (Kumari and Sen, 2015). Previous
work has demonstrated that the structural proteins CTCF and
YY1, along with the lineage-restricted transcription factor
PAX5, play key roles in this process. Specifically, loss of either
YY1 or PAX5 was associated with inefficient and biased V-to-
DJ recombination, characterized by reduced locus contraction
and loss of PAIR-associated antisense transcription, i.e., pheno-
types that bear resemblance to what we observe in the ErgD/D
mice (Ebert et al., 2011; Fuxa et al., 2004; Liu et al., 2007; Medve-
dovic et al., 2013; Verma-Gaur et al., 2012). However, in contrast
to ErgD/D mice, PAX5-deficient animals lack CD25+ B cells and
are unable to recombine to distal V gene segments, while Mb1-
Cre Yy1fl/fl mice lack CD25+ B cells and exhibit a bias against
the use of distal V gene segments (Hesslein et al., 2003; Liu
et al., 2007; Nutt et al., 1997). It is therefore conceivable that
ERG collaborates with YY1 and/or PAX5 during the latter stages
of Igh locus recombination. Locus contraction and efficient usage
of distal V gene segments have been proposed to be associated
with the establishment of so-called transcription factories. Ac-
cording to this model, PAX5-mediated PAIR-associated anti-
sense transcription, along with transcription at the 30 end of the
Igh locus, facilitates interactions between the distal V gene region
and the Em enhancer region (Verma-Gaur et al., 2012). Although
the exact order of events is not fully resolved, we note that
ERG is able to bind to both the distal region of the Igh locus in he-
matopoietic progenitor cells and an Em enhancer element in cell-
free experiments (Rivera et al., 1993; Wilson et al., 2010). These
findings are consistent with a model in which ERG is involved in
the establishment of higher-order structures at the Igh locus,
either by promoting physical contacts through space or by
driving transcriptional events, e.g., PAIR-associated antisense
transcription, connected with the formation of these structures.
In conclusion, we have identified ERG as an essential player in
B cell development, with particular importance for proper and
efficient rearrangement of the Igh locus.
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Figure 6. Inefficient and Irregular V-to-DJ Recombination in the Absence of ERG
(A) ImmunoSEQ analysis of P1–P3 progenitor cells and splenic FO and MZ B cells from Ergfl/fl and ErgD/Dmice. The bar plot shows the quantification of the total
number of detected rearrangements (templates) within each population as calculated per 10,000 sorted cells. For all cell populations, three mice of each ge-
notype were analyzed, but only samples with an equal number of sorted cells were compared in the quantification of total rearrangements. Thus, only two
replicates were included for Ergfl/fl P2, Ergfl/fl P3, and ErgD/D P3 in this plot.
(B) Fraction of the rearrangements (templates) that are productively (in-frame, no-stop codon) recombined in the P1–P3, FO, and MZ populations as assessed by
immunoSEQ.
(C) Average length of the CDR3 region in the P1–P3, FO, and MZ populations as determined using immunoSEQ.
(D) Results from the immunoSEQ analysis showing the usage of distal (blue) and proximal (purple) IghV gene families. The V gene segment usage is depicted as
the frequency of the productive rearrangements within each sample. Bars of the same color represent cells from the same mouse for the P1–P3 populations and
for the FO and MZ populations.
(E) ImmunoSEQ analysis of P1 progenitor cells showing the quantification of the total number of detected rearrangements (templates) involving distal (IghV1 and
IghV8) and proximal (IghV2 and IghV5) gene segments as calculated per 10,000 sorted cells.
(legend continued on next page)
Cell Reports 29, 2756–2769, November 26, 2019 2767
REFERENCES
Amemiya, H.M., Kundaje, A., and Boyle, A.P. (2019). The ENCODE Blacklist:
Identification of Problematic Regions of the Genome. Sci. Rep. 9, 9354.
Bagger, F.O., Sasivarevic, D., Sohi, S.H., Laursen, L.G., Pundhir, S., Sønderby,
C.K., Winther, O., Rapin, N., and Porse, B.T. (2016). BloodSpot: a database of
gene expression profiles and transcriptional programs for healthy and malig-
nant haematopoiesis. Nucleic Acids Res. 44 (D1), D917–D924.
Baldus, C.D., Burmeister, T., Martus, P., Schwartz, S., Go¨kbuget, N., Bloom-
field, C.D., Hoelzer, D., Thiel, E., and Hofmann,W.K. (2006). High expression of
the ETS transcription factor ERG predicts adverse outcome in acute
T-lymphoblastic leukemia in adults. J. Clin. Oncol. 24, 4714–4720.
Buenrostro, J.D., Wu, B., Chang, H.Y., and Greenleaf, W.J. (2015). ATAC-seq:
A Method for Assaying Chromatin Accessibility Genome-Wide. Curr. Protoc.
Mol. Biol. 109, 21.29.1–21.29.9.
Carey, J.B., Moffatt-Blue, C.S., Watson, L.C., Gavin, A.L., and Feeney, A.J.
(2008). Repertoire-based selection into themarginal zone compartment during
B cell development. J. Exp. Med. 205, 2043–2052.
Corcoran, A.E., Smart, F.M., Cowling, R.J., Crompton, T., Owen, M.J., and
Venkitaraman, A.R. (1996). The interleukin-7 receptor alpha chain transmits
distinct signals for proliferation and differentiation during B lymphopoiesis.
EMBO J. 15, 1924–1932.
de Boer, J., Williams, A., Skavdis, G., Harker, N., Coles, M., Tolaini, M., Norton,
T., Williams, K., Roderick, K., Potocnik, A.J., and Kioussis, D. (2003). Trans-
genic mice with hematopoietic and lymphoid specific expression of Cre.
Eur. J. Immunol. 33, 314–325.
Degner, S.C., Verma-Gaur, J., Wong, T.P., Bossen, C., Iverson, G.M., Torka-
mani, A., Vettermann, C., Lin, Y.C., Ju, Z., Schulz, D., et al. (2011). CCCTC-
binding factor (CTCF) and cohesin influence the genomic architecture of the
Igh locus and antisense transcription in pro-B cells. Proc. Natl. Acad. Sci.
USA 108, 9566–9571.
Dobin, A., Davis, C.A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut,
P., Chaisson,M., andGingeras, T.R. (2013). STAR: ultrafast universal RNA-seq
aligner. Bioinformatics 29, 15–21.
Ebert, A., McManus, S., Tagoh, H., Medvedovic, J., Salvagiotto, G., Novatch-
kova, M., Tamir, I., Sommer, A., Jaritz, M., and Busslinger, M. (2011). The distal
V(H) gene cluster of the Igh locus contains distinct regulatory elements with
Pax5 transcription factor-dependent activity in pro-B cells. Immunity 34,
175–187.
Ewels, P., Magnusson, M., Lundin, S., and Ka¨ller, M. (2016). MultiQC: summa-
rize analysis results for multiple tools and samples in a single report. Bioinfor-
matics 32, 3047–3048.
Fuxa, M., Skok, J., Souabni, A., Salvagiotto, G., Roldan, E., and Busslinger, M.
(2004). Pax5 induces V-to-DJ rearrangements and locus contraction of the
immunoglobulin heavy-chain gene. Genes Dev. 18, 411–422.
Gautier, L., Cope, L., Bolstad, B.M., and Irizarry, R.A. (2004). affy—analysis of
Affymetrix GeneChip data at the probe level. Bioinformatics 20, 307–315.
Gentleman, R.C., Carey, V.J., Bates, D.M., Bolstad, B., Dettling, M., Dudoit, S.,
Ellis, B., Gautier, L., Ge, Y., Gentry, J., et al. (2004). Bioconductor: open soft-
ware development for computational biology and bioinformatics. Genome
Biol. 5, R80.
Guo, C., Gerasimova, T., Hao, H., Ivanova, I., Chakraborty, T., Selimyan, R.,
Oltz, E.M., and Sen, R. (2011). Two forms of loops generate the chromatin(F) ATAC-seq tracks visualized for mm9 in the University of California Santa Cruz G
progenitor B cells. Cells from four mice of each genotype were analyzed. The c
marker combination: Lin-B220+CD19+CD93+CD43+/int.
(G) RNA-seq tracks visualized for mm10 in the Integrative Genomics Viewer (I
scription (rawRNA-seq reads) immediately next to PAIR11 (left), PAIR6 (middle), an
genotype. There was no significant difference in the total number of mapped rea
For the bar plots in (A)–(C), the data are shown as mean + SD. Statistical analyses
0.01, ***p% 0.001, ****p% 0.0001. For tracks showing ATAC-seq and RNA-seq d
gray, respectively. See also Figure S4.
2768 Cell Reports 29, 2756–2769, November 26, 2019conformation of the immunoglobulin heavy-chain gene locus. Cell 147,
332–343.
Heinz, S., Benner, C., Spann, N., Bertolino, E., Lin, Y.C., Laslo, P., Cheng, J.X.,
Murre, C., Singh, H., and Glass, C.K. (2010). Simple combinations of lineage-
determining transcription factors prime cis-regulatory elements required for
macrophage and B cell identities. Mol. Cell 38, 576–589.
Hess, J., Werner, A., Wirth, T., Melchers, F., Ja¨ck, H.M., and Winkler, T.H.
(2001). Induction of pre-B cell proliferation after de novo synthesis of the
pre-B cell receptor. Proc. Natl. Acad. Sci. USA 98, 1745–1750.
Hesslein, D.G., Pflugh, D.L., Chowdhury, D., Bothwell, A.L., Sen, R., and
Schatz, D.G. (2003). Pax5 is required for recombination of transcribed, acety-
lated, 50 IgH V gene segments. Genes Dev. 17, 37–42.
Jhunjhunwala, S., van Zelm, M.C., Peak, M.M., Cutchin, S., Riblet, R., van
Dongen, J.J., Grosveld, F.G., Knoch, T.A., and Murre, C. (2008). The 3D struc-
ture of the immunoglobulin heavy-chain locus: implications for long-range
genomic interactions. Cell 133, 265–279.
Johnston, C.M., Wood, A.L., Bolland, D.J., and Corcoran, A.E. (2006). Com-
plete sequence assembly and characterization of the C57BL/6mouse Ig heavy
chain V region. J. Immunol. 176, 4221–4234.
Kitamura, D., Roes, J., K€uhn, R., and Rajewsky, K. (1991). A B cell-deficient
mouse by targeted disruption of the membrane exon of the immunoglobulin
mu chain gene. Nature 350, 423–426.
Knudsen, K.J., Rehn, M., Hasemann, M.S., Rapin, N., Bagger, F.O., Ohlsson,
E., Willer, A., Frank, A.K., Søndergaard, E., Jendholm, J., et al. (2015). ERG
promotes the maintenance of hematopoietic stem cells by restricting their dif-
ferentiation. Genes Dev. 29, 1915–1929.
Kosak, S.T., Skok, J.A., Medina, K.L., Riblet, R., Le Beau, M.M., Fisher, A.G.,
and Singh, H. (2002). Subnuclear compartmentalization of immunoglobulin loci
during lymphocyte development. Science 296, 158–162.
Kumari, G., and Sen, R. (2015). Chromatin Interactions in the Control of Immu-
noglobulin Heavy Chain Gene Assembly. Adv. Immunol. 128, 41–92.
Li, Q., Brown, J.B., Huang, H., and Bickel, P.J. (2011). Measuring Reproduc-
ibility of High-Throughput Experiments. Ann. Appl. Stat. 5, 1752–1779.
Lilljebjo¨rn, H., Henningsson, R., Hyrenius-Wittsten, A., Olsson, L., Orsmark-
Pietras, C., von Palffy, S., Askmyr, M., Rissler, M., Schrappe, M., Cario, G.,
et al. (2016). Identification of ETV6-RUNX1-like and DUX4-rearranged sub-
types in paediatric B-cell precursor acute lymphoblastic leukaemia. Nat. Com-
mun. 7, 11790.
Lin, Y.C., Jhunjhunwala, S., Benner, C., Heinz, S., Welinder, E., Mansson, R.,
Sigvardsson, M., Hagman, J., Espinoza, C.A., Dutkowski, J., et al. (2010). A
global network of transcription factors, involving E2A, EBF1 and Foxo1, that
orchestrates B cell fate. Nat. Immunol. 11, 635–643.
Liu, H., Schmidt-Supprian, M., Shi, Y., Hobeika, E., Barteneva, N., Jumaa, H.,
Pelanda, R., Reth, M., Skok, J., Rajewsky, K., and Shi, Y. (2007). Yin Yang 1 is a
critical regulator of B-cell development. Genes Dev. 21, 1179–1189.
Loughran, S.J., Kruse, E.A., Hacking, D.F., de Graaf, C.A., Hyland, C.D., Will-
son, T.A., Henley, K.J., Ellis, S., Voss, A.K., Metcalf, D., et al. (2008). The tran-
scription factor Erg is essential for definitive hematopoiesis and the function of
adult hematopoietic stem cells. Nat. Immunol. 9, 810–819.
Love, M.I., Huber, W., and Anders, S. (2014). Moderated estimation of fold
change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550.
Lukin, K., Fields, S., Lopez, D., Cherrier, M., Ternyak, K., Ramı´rez, J., Feeney,
A.J., and Hagman, J. (2010). Compound haploinsufficiencies of Ebf1 andenome Browser (http://genome.ucsc.edu) for the Igh locus in Ergfl/fl and ErgD/D
ells underwent fluorescence-activated cell sorting (FACS) using the following
GV) browser (https://software.broadinstitute.org/software/igv/) showing tran-
d PAIR4 (right) inErgfl/fl andErgD/DP1 cells. Four replicatesweremade for each
ds between the Ergfl/fl and ErgD/D P1 samples (data not shown).
were performed using unpaired, two-tailed Student’s t test. *p% 0.05, **p%
ata, representative samples are shown. Ergfl/fl and ErgD/D tracks are black and
Runx1 genes impede B cell lineage progression. Proc. Natl. Acad. Sci. USA
107, 7869–7874.
Madsen, J.G.S., Rauch, A., Van Hauwaert, E.L., Schmidt, S.F., Winnefeld, M.,
and Mandrup, S. (2018). Integrated analysis of motif activity and gene expres-
sion changes of transcription factors. Genome Res. 28, 243–255.
Martens, J.H. (2011). Acute myeloid leukemia: a central role for the ETS factor
ERG. Int. J. Biochem. Cell Biol. 43, 1413–1416.
Medvedovic, J., Ebert, A., Tagoh, H., Tamir, I.M., Schwickert, T.A., Novatch-
kova, M., Sun, Q., Huis In ’t Veld, P.J., Guo, C., Yoon, H.S., et al. (2013). Flex-
ible long-range loops in the VH gene region of the Igh locus facilitate the
generation of a diverse antibody repertoire. Immunity 39, 229–244.
Nutt, S.L., Urba´nek, P., Rolink, A., and Busslinger, M. (1997). Essential func-
tions of Pax5 (BSAP) in pro-B cell development: difference between fetal
and adult B lymphopoiesis and reduced V-to-DJ recombination at the IgH
locus. Genes Dev. 11, 476–491.
Nutt, S.L., Heavey, B., Rolink, A.G., and Busslinger, M. (1999). Commitment to
the B-lymphoid lineage depends on the transcription factor Pax5. Nature 401,
556–562.
Parker, M.J., Licence, S., Erlandsson, L., Galler, G.R., Chakalova, L., Osborne,
C.S., Morgan, G., Fraser, P., Jumaa, H., Winkler, T.H., et al. (2005). The pre-B-
cell receptor induces silencing of VpreB and lambda5 transcription. EMBO J.
24, 3895–3905.
Patro, R., Duggal, G., Love, M.I., Irizarry, R.A., and Kingsford, C. (2017).
Salmon provides fast and bias-aware quantification of transcript expression.
Nat. Methods 14, 417–419.
Pelanda, R., Braun, U., Hobeika, E., Nussenzweig, M.C., and Reth, M. (2002).
B cell progenitors are arrested in maturation but have intact VDJ recombina-
tion in the absence of Ig-alpha and Ig-beta. J. Immunol. 169, 865–872.
Perlot, T., and Alt, F.W. (2008). Cis-regulatory elements and epigenetic
changes control genomic rearrangements of the IgH locus. Adv. Immunol.
99, 1–32.
Peschon, J.J., Morrissey, P.J., Grabstein, K.H., Ramsdell, F.J., Maraskovsky,
E., Gliniak, B.C., Park, L.S., Ziegler, S.F., Williams, D.E., Ware, C.B., et al.
(1994). Early lymphocyte expansion is severely impaired in interleukin 7 recep-
tor-deficient mice. J. Exp. Med. 180, 1955–1960.
Prohaska, T.A., Que, X., Diehl, C.J., Hendrikx, S., Chang, M.W., Jepsen, K.,
Glass, C.K., Benner, C., and Witztum, J.L. (2018). Massively Parallel
Sequencing of Peritoneal and Splenic B Cell Repertoires Highlights Unique
Properties of B-1 Cell Antibodies. J. Immunol. 200, 1702–1717.
Quinlan, A.R., and Hall, I.M. (2010). BEDTools: a flexible suite of utilities for
comparing genomic features. Bioinformatics 26, 841–842.
Rainis, L., Toki, T., Pimanda, J.E., Rosenthal, E., Machol, K., Strehl, S., Go¨tt-
gens, B., Ito, E., and Izraeli, S. (2005). The proto-oncogene ERG in megakar-
yoblastic leukemias. Cancer Res. 65, 7596–7602.
Rauch, A., Haakonsson, A.K., Madsen, J.G.S., Larsen, M., Forss, I., Madsen,
M.R., Van Hauwaert, E.L., Wiwie, C., Jespersen, N.Z., Tencerova, M., et al.
(2019). Osteogenesis depends on commissioning of a network of stem cell
transcription factors that act as repressors of adipogenesis. Nat. Genet. 51,
716–727.
Ritchie, M.E., Phipson, B., Wu, D., Hu, Y., Law, C.W., Shi, W., and Smyth, G.K.
(2015). limma powers differential expression analyses for RNA-sequencing
and microarray studies. Nucleic Acids Res. 43, e47.Rivera, R.R., Stuiver, M.H., Steenbergen, R., and Murre, C. (1993). Ets pro-
teins: new factors that regulate immunoglobulin heavy-chain gene expression.
Mol. Cell. Biol. 13, 7163–7169.
Rolink, A., Grawunder, U., Winkler, T.H., Karasuyama, H., and Melchers, F.
(1994). IL-2 receptor alpha chain (CD25, TAC) expression defines a crucial
stage in pre-B cell development. Int. Immunol. 6, 1257–1264.
Schelonka, R.L., Ivanov, I.I., Vale, A.M., Dimmitt, R.A., Khaled, M., and
Schroeder, H.W., Jr. (2011). Absence of N addition facilitates B cell develop-
ment, but impairs immune responses. Immunogenetics 63, 599–609.
Schindler, J.W., Van Buren, D., Foudi, A., Krejci, O., Qin, J., Orkin, S.H., and
Hock, H. (2009). TEL-AML1 corrupts hematopoietic stem cells to persist in
the bone marrow and initiate leukemia. Cell Stem Cell 5, 43–53.
Sigvardsson, M. (2018). Molecular Regulation of Differentiation in Early
B-Lymphocyte Development. Int. J. Mol. Sci. 19, E1928.
Soneson, C., Love, M.I., and Robinson, M.D. (2015). Differential analyses for
RNA-seq: transcript-level estimates improve gene-level inferences.
F1000Res. 4, 1521.
Subramanian, A., Tamayo, P., Mootha, V.K., Mukherjee, S., Ebert, B.L., Gil-
lette, M.A., Paulovich, A., Pomeroy, S.L., Golub, T.R., Lander, E.S., and Me-
sirov, J.P. (2005). Gene set enrichment analysis: a knowledge-based approach
for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA
102, 15545–15550.
Tsuzuki, S., Taguchi, O., and Seto, M. (2011). Promotion and maintenance of
leukemia by ERG. Blood 117, 3858–3868.
Vallespino´s, M., Ferna´ndez, D., Rodrı´guez, L., Alvaro-Blanco, J., Baena, E.,
Ortiz, M., Dukovska, D., Martı´nez, D., Rojas, A., Campanero, M.R., and Mor-
eno de Albora´n, I. (2011). B Lymphocyte commitment program is driven by
the proto-oncogene c-Myc. J. Immunol. 186, 6726–6736.
van Riggelen, J., Yetil, A., and Felsher, D.W. (2010). MYC as a regulator of ribo-
some biogenesis and protein synthesis. Nat. Rev. Cancer 10, 301–309.
Verma-Gaur, J., Torkamani, A., Schaffer, L., Head, S.R., Schork, N.J., and
Feeney, A.J. (2012). Noncoding transcription within the Igh distal V(H) region
at PAIR elements affects the 3D structure of the Igh locus in pro-B cells.
Proc. Natl. Acad. Sci. USA 109, 17004–17009.
Wilson, N.K., Foster, S.D., Wang, X., Knezevic, K., Sch€utte, J., Kaimakis, P.,
Chilarska, P.M., Kinston, S., Ouwehand, W.H., Dzierzak, E., et al. (2010).
Combinatorial transcriptional control in blood stem/progenitor cells:
genome-wide analysis of ten major transcriptional regulators. Cell Stem Cell
7, 532–544.
Young, M.D., Wakefield, M.J., Smyth, G.K., and Oshlack, A. (2010). Gene
ontology analysis for RNA-seq: accounting for selection bias. Genome Biol.
11, R14.
Zhang, Y., Liu, T., Meyer, C.A., Eeckhoute, J., Johnson, D.S., Bernstein, B.E.,
Nusbaum, C., Myers, R.M., Brown, M., Li, W., and Liu, X.S. (2008). Model-
based analysis of ChIP-Seq (MACS). Genome Biol. 9, R137.
Zhang, J., McCastlain, K., Yoshihara, H., Xu, B., Chang, Y., Churchman, M.L.,
Wu, G., Li, Y., Wei, L., Iacobucci, I., et al.; St. Jude Children’s Research Hos-
pital-Washington University Pediatric Cancer Genome Project (2016). Dereg-
ulation of DUX4 and ERG in acute lymphoblastic leukemia. Nat. Genet. 48,
1481–1489.
Zou, X., Piper, T.A., Smith, J.A., Allen, N.D., Xian, J., and Br€uggemann, M.
(2003). Block in development at the pre-B-II to immature B cell stage in mice
without Ig kappa and Ig lambda light chain. J. Immunol. 170, 1354–1361.Cell Reports 29, 2756–2769, November 26, 2019 2769
STAR+METHODSKEY RESOURCES TABLEREAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
B220 APC Thermo Fisher Scientific Cat# 17-0452-82; RRID:AB_469395
Anti-Human/Mouse CD45R (B220) APC
B220 A700 Thermo Fisher Scientific Cat# 56-0452-82; RRID:AB_891458
Anti-Human/Mouse CD45R (B220) Alexa Fluor 700
B220 APC eFluor 780 Thermo Fisher Scientific Cat# 47-0452-82; RRID:AB_1518810
Anti-Human/Mouse CD45R (B220) APC-eFluor 780
B220 PE-Cy5 Thermo Fisher Scientific Cat# 15-0452-83; RRID:AB_468756
Anti-Human/Mouse CD45R (B220) PE-Cy5
B220 PerCP BD Biosciences Cat# 553093; RRID:AB_394622
Anti-Mouse CD45R (B220) PerCP
CD3e APC Thermo Fisher Scientific Cat# 17-0031-83; RRID:AB_469316)
Anti-Mouse CD3e APC
CD3e PECy5 Thermo Fisher Scientific Cat# 15-0031-82; RRID:AB_468690
Anti-Mouse CD3e PE-Cy5
CD4 FITC Thermo Fisher Scientific Cat# 11-0041-82; RRID:AB_464892
Anti-Mouse CD4 FITC
CD4 PECy5 Thermo Fisher Scientific Cat# 15-0041-81; RRID:AB_468694
Anti-Mouse CD4 PE-Cy5
CD5 BV421 BD Biosciences Cat# 562739; RRID:AB_2737758
Anti-Mouse CD5 BV421
CD8a PECy5 Thermo Fisher Scientific Cat# 15-0081-81; RRID:AB_468705
Anti-Mouse CD8a PE-Cy5
CD16/CD32 purified BD Biosciences Cat# 553142; RRID:AB_394657
Anti-Mouse CD16/CD32 (Mouse BD Fc Block)
Purified
CD19 APC BD Biosciences Cat# 550992; RRID:AB_398483
Anti-Mouse CD19 APC
CD19 eFluor 450 Thermo Fisher Scientific Cat# 48-0193-82; RRID:AB_2734905
Anti-Mouse CD19 eFluor 450
CD19 eFluor 605 Thermo Fisher Scientific Cat# 93-0193-41; RRID:AB_1603212
Anti-Mouse CD19 eFluor 605NC
CD21 APC BD Biosciences Cat# 561770; RRID:AB_10892818
anti-Mouse CD21/CD35 APC
CD23 PE BD Biosciences Cat# 561773; RRID:AB_10895122
Anti-Mouse CD23 PE
CD25 PE BD Biosciences Cat# 553866; RRID:AB_395101
Anti-Mouse CD25 PE
CD43 APC BD Biosciences Cat# 560663; RRID:AB_1727479
Anti-Mouse CD43 APC
CD43 biotin BD Biosciences Cat# 553269; RRID:AB_2255226
Anti-Mouse CD43 Biotin
CD44 APC eFluor 780 Thermo Fisher Scientific 47-0441-82; RRID:AB_1272244
Anti-Human/Mouse CD44 APC-eFluor 780
(Continued on next page)
e1 Cell Reports 29, 2756–2769.e1–e6, November 26, 2019
Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
CD93 FITC Thermo Fisher Scientific Cat# 11-5892-82; RRID:AB_465298
Anti-Mouse CD93 (AA4-1) FITC
CD93 PECy7 Thermo Fisher Scientific Cat# 25-5892-81; RRID:AB_469658
Anti-Mouse CD93 (AA4.1) PE-Cy7
CD135 PE Thermo Fisher Scientific Cat# 12-1351-83; RRID:AB_465860
Anti-Mouse CD135 (Flt3) PE
c-kit Alexa APC 780 Thermo Fisher Scientific Cat# 47-1171-82; RRID:AB_1272177
Anti-Mouse CD117 (c-Kit) APC-eFluor 780
c-kit APC Thermo Fisher Scientific Cat# 17-1171-82; RRID:AB_469430
Anti-Mouse CD117 (c-Kit) APC
Gr1 PECy5 Thermo Fisher Scientific Cat# 15-5931-82; RRID:AB_468813
Anti-Mouse Ly-6G (Gr-1) PE-Cy5
IgM FITC (m chain-specific) Sigma-Aldrich Cat# F9259; RRID:AB_259799
Anti-Mouse IgM (mu-chain specific) FITC
IL7R biotin Thermo Fisher Scientific Cat# 13-1271-82; RRID:AB_466588
Anti-Mouse CD127 Biotin
Mac-1 APC Thermo Fisher Scientific 17-0112-82; RRID:AB_469343
Anti-Mouse CD11b APC
Mac-1 PECy5 BioLegend Cat# 101210, RRID:AB_312793
Anti-mouse/human CD11b PE-Cy5
Nk1.1 PeCy7 Thermo Fisher Scientific Cat# 25-5941-82, RRID:AB_469665
Anti-Mouse NK1.1 PE-Cy7
SA-PECF594 BD Biosciences Cat# 562318, RRID:AB_11154218
Streptavidin PE-CF594
SA-QD655 Life Technologies CAT#Q10121MP, RRID: N/A
Sca1 PB BioLegend Cat# 108120, RRID:AB_493273
Anti-mouse Ly-6A/E (Sca-1) Pacific blue
Ter119 PECy5 eBioscience 15-5921-81, RRID:AB_468809
Anti-Mouse TER-119 PE-Cy5
Chemicals, Peptides, and Recombinant Proteins
Fetal bovine serum GE healthcare CAT#SV30160.03
Pharmlyse BD Biosciences CAT#555899
Paraformaldehyde Sigma-Aldrich CAT#P6148
Saponin Fluka CAT#47036
DNase I Sigma-Aldrich CAT#D4527
DAPI Invitrogen CAT#D3571
2-mercaptoethanol Sigma-Aldrich CAT#M3148
Critical Commercial Assays
FITC BrdU flow kit BD Biosciences CAT# 559619, RRID:AB_2617060
AllPrep DNA/RNA micro kit QIAGEN CAT#80284
Ovation RNA-seq System V2 NuGEN CAT# 7102-32
Ovation Ultralow System V2 NuGEN CAT#0344-32
RNeasy micro kit QIAGEN CAT#74004
Nextera DNA Library Preparation Kit Illumina CAT#FC-121-1030
Nextera Index Kit Illumina CAT#FC-121-1011
ImmunoSEQ, mmIGH, survey resolution Adaptive biotechnologies N/A
Affymetrix’s Mouse Gene 1.0 ST GeneChip array Affymetrix N/A
(Continued on next page)
Cell Reports 29, 2756–2769.e1–e6, November 26, 2019 e2
Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
Deposited Data
RNA-seq This paper GEO: GSE128978
ATAC-seq This paper GEO: GSE128978
Microarray This paper GEO: GSE128978
ImmunoSEQ This paper immuneACCESS database (https://clients.
adaptivebiotech.com/login) DOI: 10.21417/
ES2019CR
Mouse reference genome mm9/NCBI37 Genome Reference Consortium N/A
Mouse reference genome mm10/GRCm38 Genome Reference Consortium N/A
Experimental Models: Organisms/Strains
B6-Ergflox/flox;CD2iCre Knudsen et al., 2015 N/A
Oligonucleotides
Primers for Erg genotyping PCR: ATCATGACAATA
AGCCGGGT; AACCAGAACGGTGGTAGTCT; GTG
GTGGCTCCTTAAGGGTC
Knudsen et al., 2015 N/A
Primers for CD2iCre genotyping PCR: GACAGGCAG
GCCTTCTCTGAA; CTTCTCCACACCAGCTGTGGA
Knudsen et al., 2015 N/A
Software and Algorithms
FlowJo BD https://www.flowjo.com/solutions/flowjo
RRID:SCR_008520
Prism GraphPad https://www.graphpad.com/ RRID:SCR_002798
UCSC Genome Browser University of California at Santa
Cruz; California; USA
http://genome.ucsc.edu RRID:SCR_005780
Integrative Genomics Viewer (IGV) Broad Institute http://software.broadinstitute.org/software/igv/
RRID:SCR_011793
bcbio-nextgen https://github.com/bcbio/bcbio-nextgen
STAR aligner Dobin et al., 2013 https://github.com/alexdobin/STAR
Salmon Patro et al., 2017 https://combine-lab.github.io/salmon/
FastQC http://www.bioinformatics.babraham.ac.uk/
projects/fastqc/
multiqc Ewels et al., 2016 https://multiqc.info/
R/Bioconductor Gentleman et al., 2004 https://www.R-project.org/
Differential gene expression recommendations Soneson et al., 2015
limma package Ritchie et al., 2015 https://bioconductor.org/packages/release/bioc/
html/limma.html
GSEA Subramanian et al., 2005 http://software.broadinstitute.org/gsea/index.jsp
MSigDB http://software.broadinstitute.org/gsea/msigdb
Bioconductor (Affy package, RMA) Gautier et al., 2004 http://bioconductor.org/packages/release/bioc/
html/affy.html
ENCODE IDR pipeline Li et al., 2011 https://github.com/nboley/idr
MACS2 Zhang et al., 2008 https://github.com/taoliu/MACS
HOMER Heinz et al., 2010 http://homer.ucsd.edu/homer/
DEseq2 Love et al., 2014 https://bioconductor.org/packages/release/bioc/
html/DESeq2.html
goseq Young et al., 2010 https://bioconductor.org/packages/release/bioc/
html/goseq.html
IMAGE Madsen et al., 2018 https://www.sdu.dk/en/om_sdu/institutter_centre/
bmb_biokemi_og_molekylaer_biologi/forskning/
forskningsgrupper/functionalgenomics/
bioinformatics+tools
Bedtools Quinlan and Hall, 2010 http://bedtools.readthedocs.io/en/latest/
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LEAD CONTACT AND MATERIALS AVAILABILITY
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Bo T.
Porse (bo.porse@finsenlab.dk). This study did not generate any new unique reagents.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Animals
Ergfl/fl and Ergfl/fl;CD2iCre (ErgD/D) mice were bred as described in Knudsen et al. (2015). In short, mice, in which the ETS domain-
containing exon of Erg is flanked by LoxP sites, were crossed tomice harboringCD2iCre,which drives a lymphoid-restricted expres-
sion of iCre. The mice were backcrossed onto a C57BL/6J background for at least 6 generations. The mice were bred and housed in
individually ventilated cages (IVC) at the Department of Experimental Medicine at the University of Copenhagen according to insti-
tutional guidelines. Experiments were carried out with permissions from the Danish Animal Research Ethical Committee. 10-14 week
old female mice were used for all analyses unless specifically stated.
METHOD DETAILS
Genotyping
A three-primer system (ATCATGACAATAAGCCGGGT; AACCAGAACGGTGGTAGTCT; GTGGTGGCTCCTTAAGGGTC) was used
for PCR genotyping of Erg resulting in bands of the following sizes: 397bp (Ergfl), 302bp (ErgD) and 340bp (Erg+).CD2iCre genotyping
was done using two primers (GACAGGCAGGCCTTCTCTGAA; CTTCTCCACACCAGCTGTGGA) giving rise to a 522bp PCR product.
Mouse experiments
For BrdU incorporation analysis, mice were subjected to intraperitoneal injection of 200ml PBS containing 2mg BrdU (Sigma-Aldrich,
B5002), and BM was collected three h later.
Flow cytometry
Bones were harvested by dissection of the hindlegs (2x tibia, femur, illium), and crushed in PBS+3% fetal bovine serum (FBS, GE
healthcare, Little Chalfont, UK). Thymus and spleen were dissected and the cells were homogenized in PBS+3% FBS and filtered
through a 70mm cell strainer.
Cells in single cell suspension were blocked with CD16/CD32 and incubated with antibodies for 20-25min. The cells were subse-
quently stained with a secondary antibody when applicable. For FACS, cells were treated with PharmLyse (BD, Franklin Lakes, New
Jersey, USA) for 5min to reduce the amount of red blood cells.
For intracellular staining, cells (stained for cell-surface antigens) were fixed for 5min in PBS+1% paraformaldehyde (PFA) (Sigma-
Aldrich, St. Louis, Missouri, USA) and permeabilized with PBS+0.1% saponin (Fluka) at RT for 10min. The cells were blocked with
CD16/32 before antibody incubation. For the analysis of BrdU incorporation, cells (stained for cell-surface antigens) were fixed, per-
meabilized, treated with DNase I (D4527, Sigma-Aldrich) and stained with anti-BrdU antibody using a FITC BrdU Flow kit (BD) ac-
cording to manufacturer’s instructions.
Finally, for cell cycle analyses, cells (stained for cell-surface antigens) were fixed for 10min in PBS+2% PFA at room temperature
(RT) and permeabilized with PBS+0.1% saponin at RT for 45min before being stained for 30min with DAPI (0.5mg/mL) (Invitrogen,
Carlsbad, California, USA).
Flow cytometry analyses were carried out using a BD Accuri C6 or LSR II instrument, and cells were sorted on BD Aria I or III in-
struments. FlowJo software (BD) was used for subsequent analyses.
Cells were analyzed and sorted according to the following surface markers:
BM: P1 (B220+, CD19+, CD93+, CD43+, CD25-), P2 (B220+, CD19+, CD93+, CD43+, CD25+), P3 (B220+, CD19+, CD93+,
CD43-, CD25+), c-Kit, CD43+ (B220+, CD19+, CD93+, CD43+, c-Kit+), immature B cells (B220+, CD19+, CD93+, IgM+), mature
B cells (B220+, CD19+, CD93-, IgM+).
Spleen: T1 B cells (CD19+, CD43-, CD93+, IgM+, CD23-), T2 B cells (CD19+, CD43-, CD93+, CD23+), B1 B cells (CD19+, CD43+),
marginal zone B cells (CD19+, CD43-, CD93-, CD21hi, CD23-), follicular B cells (CD19+, CD43-, CD93-, CD21+/int, CD23+), B1a B
cells (B220+, CD19+, CD43+, IgM+, CD5+), B1b B cells (B220+, CD19+, CD43+, IgM+, CD5-), CD4+ T cells (CD3e+, CD4+), CD8+
T cells (CD3e+, CD8a+), all B cells (B220+).
Thymus: B cells (B220+), CD4+ T cells (CD4+, CD8a-), CD8+ T cells (CD4-,CD8a+), DP (CD4+, CD8a+), DN (CD4-, CD8a-), DN1
(CD4-, CD8a-, CD44+, CD25-), DN2 (CD4-, CD8a-, CD44+, CD25+), DN3 (CD4-, CD8a-, CD44-, CD25+), DN4 (CD4-, CD8a-,
CD44-, CD25-). DP and DN indicate double positive and double negative, respectively.
Peripheral blood: B cells (CD19+), CD4+ T cells (CD4+), CD8+ T cells (CD8a+), myeloid cells (Mac-1+), NK cells (Nk1.1+).
Lymph nodes: B cells (B220+).Cell Reports 29, 2756–2769.e1–e6, November 26, 2019 e4
For ATAC-seq and gene expression microarrays, progenitor B cells (Lin-, B220+, CD19+, CD93+ CD43+/lo) were sorted. For Erg
PCR recombination analysis, the following cells were sorted: MPPs (Lin-, Sca1+, c-Kit+, CD150-), CLPs (Lin-, Sca1lo, c-Kitlo, Flt3L+,
IL7Ra+), prepro-B (Lin-, B220+, CD19-, CD93+ CD43+/lo), pro-B (Lin-, B220+, CD19+, CD93+ CD43+/lo), pre-B+B (Lin-, B220+,
CD19+, CD43-), splenic B cells (B220+).
Gene expression analysis
RNA-seq-based
Progenitor B cells were sorted into RLT plus buffer (QIAGEN, Hilden, Germany) with 2-mercaptoethanol (Sigma-Aldrich, 10ml/mL RLT
buffer). The RNAwas extracted with QIAGEN’s AllPrepmicro kit. cDNAwas obtained using the Ovation RNA-seq System V2 (Nugen,
Redwood City, California, USA), and libraries were prepared with the Ovation Ultralow System V2 (Nugen), all according to manufac-
turer’s instructions. The samples were sequenced on an Illumina NextSeq 500 instrument (San Diego, California, USA). RNA-seq
reads were aligned to the mm10 genome using STAR (Dobin et al., 2013) and the RNA-seq tracks were visualized in the IGV browser
(http://software.broadinstitute.org/software/igv/).
Microarray-based
Progenitor B cells were sorted into RLT plus buffer with 2-mercaptoethanol (10ml/ml RLT buffer). Total RNA was extracted using the
RNeasy micro kit (QIAGEN), and libraries were obtained using the Ovation Pico WTA system V2 (NuGEN) following manufacturer’s
instructions. The libraries were hybridized to the Mouse Gene 1.0 ST GeneChip array (Affymetrix, Santa Clara, California, USA).
ERG gene expression
ERG expression levels during the early stages of B- and T cell development were assessed via publicly available gene expression
repositories using the Bloodspot database (Bagger et al., 2016).
ATAC-seq analyses
Genome-wide analyses of chromatin accessibility
ATAC-seq was performed on 10,000 sorted progenitor B cells as previously described (Buenrostro et al., 2015). Briefly, sorted cells
were permeabilized and exposed to 0.5ml transposase. Library amplification was done using the Nextera DNA library Prep kit (Illu-
mina) according to the instructions by the manufacturer, and sequencing was performed on a HiSeq 1500 Illumina machine.
Sequencing reads were mapped to the mouse genome (mm9) using STAR (Dobin et al., 2013). The ATAC-seq data were visualized
using the UCSC browser (http://genome.ucsc.edu).
ImmunoSEQ
Sorted progenitors andmature B cells were subjected to immunoSEQ assessing the VDJ junctions of the Igh locus. The immunoSEQ
assay utilizes a bias-controlled multiplex PCR (using gene segment-specific primers) followed by next-generation sequencing in or-
der to allow identification of the CDR3 sequences of the recombined antigen receptor loci.
60,000 mature B cells or 10,000-30,000 progenitor B cells were sorted, pelleted, and frozen at 80C. The pellets were sent to the
facilities of Adaptive Biotechnologies (Seattle, Washington, USA) according to their instructions for further processing. The cells were
assessed for the murine Igh locus (gDNA) at survey resolution (used for samples with low cell numbers). The online immunoSEQ
analyzer software was used for extracting data.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical details of the experiments (e.g., statistical tests used, value of n, definition of center, and dispersion and precision mea-
sures) are stated in the figures, the figure legends and/or under the relevant section of the STAR Methods. Generally, unless stated
otherwise in the figure legends or STAR Methods, we have used unpaired, two-tailed Student’s t test and visualized the results as
barplots showing mean + SD, when two conditions were compared. n represents the number of biological replicates. Statistical sig-
nificance is defined as p value% 0.05. * = p% 0.05, ** = p% 0.01, *** = p% 0.001, **** = p% 0.0001.
Gene expression analysis
RNA-seq-based
RNA-seq data were analyzed with bcbio-nextgen (https://github.com/bcbio/bcbio-nextgen). Fastq files were aligned to the mm10
genome using STAR (Dobin et al., 2013). Transcript expression levels were estimated with Salmon (Patro et al., 2017). FastQC
(http://www.bioinformatics.babraham.ac.uk/projects/fastqc/) was used for QCmetrics, andmultiqc (Ewels et al., 2016) for reporting.
Data analysis was then performed with R/Bioconductor (https://www.R-project.org/; Gentleman et al. (2004)). For the differential
gene expression, we followed the recommendations from Soneson et al. (2015). Gene expression levels were assessed by adding
all the transcript levels for a given gene and normalization of the counts was done with the lengthScaledTPM function of the tximport
package followed by a limma-voom procedure: for each population (P1-3), genes with CPM > 1 in at least 2 samples were selected,
the TMM normalization was run using the calcNormFactors function of the limma package (Ritchie et al., 2015), and a linear model
with ErgD/D versus Ergfl/fl was fitted (voom / lmFit / eBayes). P values were adjusted using the Benjamini-Hochberg procedure.e5 Cell Reports 29, 2756–2769.e1–e6, November 26, 2019
Gene set enrichment analysis was carried out using GSEA (http://software.broadinstitute.org/gsea/index.jsp) (Subramanian et al.,
2005). Gene sets originated from the MSigDB (http://software.broadinstitute.org/gsea/msigdb).
Microarray-based
Microarray data were normalized using RMA (Bioconductor) (Gautier et al., 2004). Differential expression analysis was performed us-
ing the limma package (Ritchie et al., 2015) with uncorrected and corrected p values (modified smyth t test) being reported for each
probeset.
ATAC-seq analyses
Sequencing reads were mapped to the mouse genome (mm9) using STAR (Dobin et al., 2013). The ATAC-seq data were visualized
using the UCSC browser (http://genome.ucsc.edu). ATAC-seq sites were identified according to the ENCODE IDR pipeline (Li et al.,
2011) using MACS2 (Zhang et al., 2008) peak calling from each replicate. IDR p value was calculated for pairwise combinations of
replicates (6 combinations for 4 replicates a to d; a:b, a:c, a:d, b:c, b:d, c:d). For all downstream analyses, ATAC-seq sites scoring
a p value < 0.05 in at least 4 out of 6 combinations were merged across both genotypes followed by filtering for the mouse ENCODE
blacklist (Amemiya et al., 2019) using bedtools (Quinlan and Hall, 2010). Sequencing tags in peaks were quantified using HOMER
(Heinz et al., 2010) allowing only one read per position per length and differential accessibility was determined using DEseq2
(Love et al., 2014). Dynamic ATAC-sites were defined as sites with a significant change in ATAC-seq signal (Benjamini-Hochberg
correction FDR < 0.01) between Ergfl/fl and ErgD/D mice.
Gene ontology analysis of genes in the vicinity of dynamic ATAC-seq sites
Genes with transcription start site ± 50 kb from ATAC-seq sites with differential accessibility between Ergfl/fl and ErgD/D progenitor B
cells were subjected to gene ontology analysis using goseq (Young et al., 2010). Biological processes reaching a p value < 0.01 after
Benjamini-Hochberg correction were reported.
IMAGE based modeling of motif activity and network analysis
We used the IMAGE tool (Madsen et al., 2018) to compute the contribution of motifs first to chromatin accessibility as defined by the
ATAC-seq signal in all ATAC-seq regions (n = 52311) and second to gene expression as defined by the microarray signal for each
biological replicate (ATAC-seq n = 4 andmicroarray n = 3 per genotype). Dynamicmotifs were defined by a significant change inmotif
activity (p value < 0.01) when comparing progenitor B cells from Ergfl/fl and ErgD/D mice. IMAGE output further contains predicted
target regions and target genes for each motif which was used to build a transcriptional network. Network visualization was done
with the R package igraph. To estimate the connectivity within the group of transcription factors that either lost or gainedmotif activity
in ErgD/D progenitor B cells compared to Ergfl/fl cells, we determined how many group members were targeted by each individual
transcription factor of the group. The values were normalized by group size and averaged over all group members. In order to control
for a possible network bias, we performed 1000 randomizations in which edges of the network were shuffled while keeping the spe-
cific number of target transcription factors among all targets constant. For each permutation we determined the connectivity, and
permutation results are represented as mean including standard deviation over 1000 permutations. A p value was generated by
asking how often the shuffled network reached at least or exceeded the values of the real distribution.
Statistics and reproducibility
ATAC-seq andmicroarray datawere generated from isolated progenitor B cells of independent Ergfl/fl andErgD/Dmice (not paired). All
boxplots depict the first and third quartiles as the lower and upper bounds of the box, with a thicker band inside the box showing the
median value and whiskers representing 1.5 3 the interquartile range. FDR tests for differential chromatin accessibility and gene
ontology enrichment were done using Benjamini-Hochberg procedure integrated in R packages DEseq2 (Love et al., 2014) and go-
seq (Young et al., 2010). P values derived from randomization tests indicate the number of trials yielding similar or higher values than
the true distribution divided by 1000.
DATA AND CODE AVAILABILITY
The accession number for the RNA-seq data, microarray gene expression data, and ATAC-seq data http://www.ncbi.nlm.nih.gov/
gds reported in this paper is GEO: GSE128978. ImmunoSEQ data are available in the immuneACCESS database (https://clients.
adaptivebiotech.com/login), https://doi.org/10.21417/ES2019CR.Cell Reports 29, 2756–2769.e1–e6, November 26, 2019 e6
